Most notably, when we treated mice bearing PDX with RP-B7-H3 CAR T cells derived from a metastatic TNBC patient, CR was obtained in 100% of mice, accompanied by increased CAR T cell in vivo expansion and long-lasting tumor-free survival. The gene discussed is CD80; the disease is neoplasm.